Jose Perez has an extensive background in cell pharmacology, assay development, and drug discovery. With experience in various leadership roles at C4 Therapeutics, Inc., Broad Institute, MSCRF/Tedco, and Pfizer Global R&D, Jose has a strong foundation in biochemical and cellular assay development, signal transduction, and molecular biology. Jose also pursued postdoctoral research in oncology at Hoffmann-La Roche after earning their Ph.D. in Biochemistry from The University of Vermont. Jose holds a B.S. in Biochemistry from Albright College.
January, 2022 - present
May, 2018